Botanical species · safety record

Hedysarum polybotrys

The EFSA Compendium of Botanicals holds 8 constituent measurements for Hedysarum polybotrys. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hedysarum polybotrys Hand.-Mazz.

8Constituent measurements
0Safety records
6Cited sources
3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Hedysarum polybotrys as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Root

What the records describe

Constituents measured

  • Calycosin1
  • Formononetin1
  • Furan derivatives1
  • Isoflavones1
  • Ononin1
  • Phenylpropanoids1
  • Saponins1
  • Triterpene saponins1

Plant parts

  • Roots and other underground parts4
  • Unspecified4

Preparations

  • Solvent extraction3
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
IsoflavonesRoots and other underground partsSolvent extractionHPLC-DADResolve DOI
PhenylpropanoidsRoots and other underground partsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Triterpene saponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CalycosinUnspecifiedStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
FormononetinUnspecifiedStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Furan derivativesUnspecifiedEssential oil4.8 PercentGC-MSNo resolvable identifier
OnoninUnspecifiedStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
SaponinsRoots and other underground partsHPLC-ELSDNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Cheng Fan., Zou Kun., Zhu Shu., Katsuko, Komatsu. A New Phenylpropionate Derivative from the Rhizomes of Hedysarum polybotrys . Chinese journal of natural medicines, 2009, vol. 7, no. 5, p. 351-353. DOI
  2. Hai Li-qian., Zhang Qing-ying., Liang Hong., Zhao Yu-ying., Du Nian-sheng. Studies on chemical constituents of Hedysarum polybotrys.. Yaoxue xuebao, 2003, vol. 38, no. 8, p. 592-595.
  3. Zhao, Jing., Yu, Qing-Tao., Li, Ping., Zhou, Peng., Zhang, Yuan-Jie., Wang, Wei. Determination of nine active components in Radix Hedysari and Radix Astragali using capillary HPLC with diode array detection and MS detection . Journal of separation science, 2008, vol. 31, no. 2, p. 255-261. DOI
  4. Chen, Yaozu., Wang, Rui., Xue, Dongyuan., Li, Zhaolin., Han, Hui. Analysis of volatile constituents of Hedysarum polybotrys Hand. by capillary gas chromatography-mass spectrometry. Gaodeng xuexiao huaxue xuebao, 1987, p. 538-541.
  5. Liu, Yi., Zhao, Yuying., Chen, Hubiao., Wang, Bin., Zhang, Qingying. Structure elucidation and complete NMR spectral assignment of two triterpenoid saponins from Radix Hedysari. FITOTERAPIA, 2009, vol. 80, no. 2, p. 127-129. DOI
  6. Qin, Hongping., Lu, Jing., Lin, Ruichao. Determination of astragaloside I, II, III and IV in Radix Astragali by HPLC-ELSD. Zhongcaoyao, 2009, p. 471-473.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue